Shopping Cart
- Remove All
- Your shopping cart is currently empty
A-802715 is a novel methylxanthine derivative that decreases the endogenous formation and blood levels of pro-inflammatory substances and increases the formation and blood levels of anti-inflammatory substances such as interleukin 10 receptor and tumor necrosis factor receptor.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $129 | 5 days | |
2 mg | $176 | 5 days | |
5 mg | $263 | 5 days | |
10 mg | $419 | 5 days | |
25 mg | $828 | 5 days | |
1 mL x 10 mM (in DMSO) | $186 | 5 days |
Description | A-802715 is a novel methylxanthine derivative that decreases the endogenous formation and blood levels of pro-inflammatory substances and increases the formation and blood levels of anti-inflammatory substances such as interleukin 10 receptor and tumor necrosis factor receptor. |
In vitro | The toxicity of the methylxanthine derivative A802715 was evaluated using vital dye staining assays against two human melanoma lines, Be11 and MeWo, and two human squamous cell carcinoma lines, 4197 and 4451. A802715 demonstrated the highest toxicity, with a TD50 of 0.9-1.1 mM. BrdU incorporation assays in p53 wt cells indicated that A802715 significantly enhances irradiation-induced suppression of S-phase entry. Depending on the p53 status, A802715 either prolongs the G2/M block or remains ineffective [1]. |
Molecular Weight | 322.4 |
Formula | C16H26N4O3 |
Cas No. | 107767-58-8 |
Smiles | CCCn1cnc2n(C)c(=O)n(CCCCC(C)(C)O)c(=O)c12 |
Relative Density. | 1.22 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 60 mg/mL (186.10 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.